Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Bullboard Posts
Comment by tuesdaynightridon Oct 30, 2014 12:54pm
165 Views
Post# 23077376

RE:Canadian Insider

RE:Canadian InsiderCanadian Insider is a good indicator of insider confidence and is good to keep an eye on! I also pop into Sedar regularly to keep tabs on the 4 Canadian holdings I own to make sure nothing slips by. Theralase does not exactly instill confidence when they won't comment on the many e- mails recently sent to them from this board. This was not the case 6 months ago. If a Zacks, MarketWatch, Cantech or another of the several interviews from 1st half 2014 were repeated, then hopefully someone would ask the type questions discussed here. Korelin did not ask the status questions this last time as they did in prior interviews. The fact that they cannot cash in on their options granted until at least the $0.50 level a good sign. Therefore, breaking substantially above $0.50 without seeing insider sales would be a great sign of management confidence. Good, factual data and a timeline that is back on track would cure all. Let's hope at least some of this comes out in their November Annual mtg!
Bullboard Posts